Boothbay Fund Management, LLC Athenex, Inc. Transaction History

Boothbay Fund Management, LLC

  • $3.37 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$2.97 - $4.84 $67,359 - $109,771
-22,680 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$3.71 - $5.13 $84,142 - $116,348
22,680 New
22,680 $105,000
Q1 2020

May 15, 2020
SELL
$5.71 - $15.85 $199,850 - $554,750
-35,000 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$9.6 - $17.75 $336,000 - $621,250
35,000 New
35,000 $534,000

Others Institutions Holding ATNX

# of Institutions
3
Shares Held
1.46M
Call Options Held
0
Put Options Held
0
View Full List

About Athenex, Inc.

ATNX Quotes by TradingView
  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email